Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation
Objective: Recent WHO 2017 guidelines mandates mutational analysis for the diagnosis of myeloproliferative disorders (MPN). JAK2V617F has been found in only 50-60% of Primary myelofibrosis (PMF) and Essential thrombocythaemia (ET). A recently discovered somatic Calreticulin (CALR) mutation has been...
Main Authors: | Sanjeet ROY, Marie Therese MANIPADAM, Poonkuzhali BALASUBRAMANIAN |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2022-01-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1988
|
Similar Items
-
The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
by: Jingyi Wang, et al.
Published: (2016-08-01) -
The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up
by: Amina Kurtovic-Kozaric, et al.
Published: (2020-05-01) -
The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms
by: Tanja Belčič Mikič, et al.
Published: (2021-03-01) -
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow
by: Morten Orebo Holmström, et al.
Published: (2023-08-01) -
Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases
by: Farah Perveen Mughal, et al.
Published: (2022-06-01)